Investigation and a potential class action lawsuit against Wyeth and others related to the sale of ProMeris.
ProMeris is a topical treatment for fleas and ticks that is sold for use on cats and dogs as young as eight weeks old. This investigation focuses on allegations that ProMeris is not effective in controlling flea and tick outbreaks, and may contains ingredients that can result cause vomiting, drooling, disorientation, skin irritation, spasms, and other adverse health effects on pets. If you have purchased ProMeris for use on a cat or dog, please contact the attorneys below.
Defendant Details
Name (Stock Symbol)
Brief Description
Wyeth (WYE)
Wyeth is a pharmaceutical company. It is now a subsidiary of Pfizer.